TAG / PSYCHIATRIC DRUGS

A 10‑member FDA panel met amid mounting evidence that antidepressants may impair fetal brain development.

The Department of Veterans Affairs partners with Big Pharma to fuel “treatment” that triggers the very suicides it claims to prevent.

Six years after doctors petitioned for Post-SSRI Sexual Dysfunction label warnings, the FDA has done nothing. Now, victims are speaking out—before more lives are destroyed.

Coercive psychiatry shifts from institutional asylums to mobile clinics, extending control over vulnerable populations under the guise of “treatment.”

Swiss study finds only seven flawed papers on Post-Acute Withdrawal Syndrome after antidepressants, while 46 percent of those withdrawing face symptoms they describe as “extremely severe.”

Psychiatric drug side effects like akathisia are too often dismissed—until it’s too late.

The state’s groundbreaking law demands public accountability and total transparency on psychiatric drugs tied to mass murder.

From cozy relationships to blockbuster approvals, a new FDA policy promises transparency after decades of industry entanglement. But is it too little, too late?

A new study reveals that nearly 1 in 10 adults prescribed ADHD drugs are addicted—many without ever “misusing” them—in an epidemic the psychiatric industry fuels for profit.

A 2024 study by the British Medical Journal has exposed a sordid conflict of interest between Big Pharma and members of the American Psychiatric Association.